<img height="1" width="1" src="https://www.facebook.com/tr?id=200201724533423&amp;ev=PageView &amp;noscript=1">
Contact Us

    DEEP MENTAL HEALTH HERITAGE & EXPERTISE

    Screen Shot 2020-01-11 at 3.28.45 PM

    Dr. Ronald Dozoretz, MD
    Founder, April 1935 - May 2020

    Developed by Clinicians for Clinicians

    Our founders are world renowned clinicians and scientists with a legacy in compassionate patient care and psychiatric innovation - core values that guide our commitment to giving clinicians the most progressive tools that can help improve the lives of people with mental illness.

     

    Our Mission: Advancing Precision Medicine for Mental Health Care

    Nearly 1 in 5 individuals suffer from mental illness, and many experience a painful process of treatment by trial and error. Our mission is to improve the quality of life for people with mental illness by using innovative technologies and collaborative expertise to advance personalized treatment plans. We will do this by empowering clinicians with unmatched genetic guidance designed to improve patient outcomes. 

    As a mental health education and technology leader, Genomind® is recognized as a global authority in the genetics of mental health.

     

    SCIENTIFIC AWARDS & RECOGNITION

    “FASTEST-GROWING U.S. PRIVATE FIRMS” inc5000-logo-2019-badge

     

    “BEST PLACES TO WORK IN HEALTHCARE” Modern Healthcare

     

    "2017 HEALTHCARE INNOVATOR AWARD” Philadelphia Business Journal

     

    “EMERGING COMPANY OF THE YEAR” Life Sciences Pennsylvania

     

    GENOMIND LEADERSHIP

     

    Our founders are world renowned clinicians and scientists with a legacy of compassionate patient care and psychiatric innovation -- core values that guide our commitment to give clinicians the most progressive tools that can help improve the lives of people with mental illness.

    Read more about the experts who are the driving force behind our advances in mental health.

    Dr. David Krause

    Co-Chief Executive Officer

    Dr. David Krause is Chief Medical Officer at Genomind. Board certified in internal medicine, Dr. Krause has more than...

    Cynthia

    Cynthia Kilroy

    Co-Chief Executive Officer

    As Chief Strategy and Corporate Development Officer, Ms. Kilroy is responsible for the development of the...

    David Robbins, PhD

    CHIEF SCIENTIFIC OFFICER

    Dr. Robbins serves as Chief Scientific Officer and is responsible for all aspects of laboratory operations at Genomind...

    Jon Levine

    CHIEF INFORMATION OFFICER

    As Chief Information Officer, Mr. Levine is responsible for all aspects of our information technology, services...

    SCIENTIFIC ADVISORY BOARD MEMBERS

     

    Scott T. Aaronson, MD

     

    Dr. Aaronson specializes in treatment-resistant affective disorders. He is a thought leader in the areas of biological psychiatry, diagnosis and the integration of somatic and psychological therapies...

    Ruth Benca MD, PhD

     

    Dr. Ruth Benca is the Chair of Psychiatry and Human Behavior at the University of California Irvine (UCI), where she has built a comprehensive sleep medicine center focused on providing...

    Kathleen Brady MD, PhD

     

    Dr. Kathleen Brady serves as the Vice President for Research at the Medical University of South Carolina (MUSC). She is an experienced clinical and translational researcher who has been working...

    Stephen V. Faraone, Ph.D

     

    Stephen Faraone, PhD, is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University and Director of Research for the...

    Maurizio Fava, MD

     

    Dr. Fava is Director, Division of Clinical Research of the Massachusetts General Hospital (MGH) Research Institute, Executive Vice Chair of the Department of Psychiatry...

    Anil Malhotra, MD

     

    Dr. Malhotra is the Director of Psychiatry Research at the Zucker Hillside Hospital in Glen Oaks, NY, Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine (AECOM) in...

    Roy H. Perlis, MD, MSc

     

    Dr. Perlis’ clinical work and research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder. He is the author of more than...

    Stephen R Saklad, PharmD

     

    Stephen R Saklad, PharmD, BCCP has joined Genomind’s SAB. Dr. Saklad is Clinical Professor of Pharmacotherapy, Adjoint Professor at the University of Texas School of Medicine, and Director...

    Naomi M. Simon, MD, MSc

     

    Dr. Naomi M. Simon is Professor of Psychiatry at NYU School of Medicine, Vice Chair for Research Faculty Development and Mentorship, and Director of the Anxiety and Complicated Grief...

    stephen-m-stahl

    Stephen M. Stahl, MD, PhD

     

    An author of over 425 articles and more than 1500 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry...

    Mark A. Stein, Ph.D., ABPP

     

    Mark A. Stein, PhD, ABPP, is the Director of PEARL Clinic/ADHD and Related Disorders Program at Seattle Children’s Hospital and an Investigator at Seattle Children’s Research Institute...